Found to inhibit HCV activity by approximately 90% Data from a late-breaking abstract presented at the International Liver CongressTM 2014 identifies a new compound, SBEL1, that has the abil... Read more
The Holy Grail of nanotherapy University of Florida researchers have moved a step closer to treating diseases on a cellular level by creating a tiny particle that can be programmed to shut d... Read more
It will take at least five years before the vaccine can be put forwards for regulatory approval After many years of research a group of Canadian scientists have announced a possible breakthr... Read more
It may be five to seven years before the vaccine receives approval A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine tha... Read more
The treatment of hepatitis C virus infections has taken a major step forward with the U.S. Food and Drug Administration’s approval of two new drugs, telaprevir and boceprevir, for managing t... Read more